Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory Sliwoski

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Journal of Computer-Aided Molecular Design|January 2, 2016
Autocorrelation descriptor improvements for QSAR: 2DA_Sign and 3DA_SignGregory Sliwoski, Jeffrey Mendenhall, Jens Meiler
Molecules (Basel, Switzerland)|August 22, 2012
BCL::EMAS--enantioselective molecular asymmetry descriptor for 3D-QSARGregory Sliwoski, Edward W Lowe, Mariusz Butkiewicz, et al.
Pharmacological Reviews|January 2, 2014
Computational methods in drug discoveryGregory Sliwoski, Sandeepkumar Kothiwale, Jens Meiler, et al.
Plos One|June 14, 2016
Discovery of Small-Molecule Modulators of the Human Y4 ReceptorGregory Sliwoski, Mario Schubert, Jan Stichel, et al.
Chemmedchem|January 16, 2022
Mapping the Binding Sites of UDP and Prostaglandin E2 Glyceryl Ester in the Nucleotide Receptor P2Y<sub>6</sub>Anne Zimmermann, Oanh Vu, Antje Brüser, et al.
Scientific Reports|May 26, 2017
Prostaglandin E<sub>2</sub> glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y<sub>6</sub>Antje Brüser, Anne Zimmermann, Brenda C Crews, et al.
Journal of Medicinal Chemistry|August 11, 2017
Identification and Characterization of the First Selective Y<sub>4</sub> Receptor Positive Allosteric ModulatorMario Schubert, Jan Stichel, Yu Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
Correction: <i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Biochemistry|August 5, 2016
Protocols for Molecular Modeling with Rosetta3 and RosettaScriptsBrian J Bender, Alberto Cisneros, Amanda M Duran, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Journal of Computer-Aided Molecular Design|January 2, 2016
Autocorrelation descriptor improvements for QSAR: 2DA_Sign and 3DA_SignGregory Sliwoski, Jeffrey Mendenhall, Jens Meiler
Molecules (Basel, Switzerland)|August 22, 2012
BCL::EMAS--enantioselective molecular asymmetry descriptor for 3D-QSARGregory Sliwoski, Edward W Lowe, Mariusz Butkiewicz, et al.
Pharmacological Reviews|January 2, 2014
Computational methods in drug discoveryGregory Sliwoski, Sandeepkumar Kothiwale, Jens Meiler, et al.
Plos One|June 14, 2016
Discovery of Small-Molecule Modulators of the Human Y4 ReceptorGregory Sliwoski, Mario Schubert, Jan Stichel, et al.
Chemmedchem|January 16, 2022
Mapping the Binding Sites of UDP and Prostaglandin E2 Glyceryl Ester in the Nucleotide Receptor P2Y<sub>6</sub>Anne Zimmermann, Oanh Vu, Antje Brüser, et al.
Scientific Reports|May 26, 2017
Prostaglandin E<sub>2</sub> glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y<sub>6</sub>Antje Brüser, Anne Zimmermann, Brenda C Crews, et al.
Journal of Medicinal Chemistry|August 11, 2017
Identification and Characterization of the First Selective Y<sub>4</sub> Receptor Positive Allosteric ModulatorMario Schubert, Jan Stichel, Yu Du, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2019
Correction: <i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
Biochemistry|August 5, 2016
Protocols for Molecular Modeling with Rosetta3 and RosettaScriptsBrian J Bender, Alberto Cisneros, Amanda M Duran, et al.
Pageof 1